Baird analyst Brian Skorney is incrementally positive on Amgen's (NASDAQ: AMGN) initial AMG 420 results."We think the very first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE